Ab Corporate Bond Etf Performance
| EYEG Etf | USD 36.22 0.07 0.19% |
The entity owns a Beta (Systematic Risk) of -0.017, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning AB Corporate are expected to decrease at a much lower rate. During the bear market, AB Corporate is likely to outperform the market.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days AB Corporate Bond has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable technical and fundamental indicators, AB Corporate is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
1 | Trend Tracker for - Stock Traders Daily | 09/26/2024 |
2 | Acquisition by Chaney Paul G of 50000 shares of AB Corporate subject to Rule 16b-3 | 09/27/2024 |
3 | AB Corporate Bond ETF goes ex dividend today | 12/02/2024 |
EYEG |
AB Corporate Relative Risk vs. Return Landscape
If you would invest 3,640 in AB Corporate Bond on September 4, 2024 and sell it today you would lose (18.00) from holding AB Corporate Bond or give up 0.49% of portfolio value over 90 days. AB Corporate Bond is currently does not generate positive expected returns and assumes 0.3407% risk (volatility on return distribution) over the 90 days horizon. In different words, 3% of etfs are less volatile than EYEG, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
AB Corporate Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for AB Corporate's investment risk. Standard deviation is the most common way to measure market volatility of etfs, such as AB Corporate Bond, and traders can use it to determine the average amount a AB Corporate's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.021
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | EYEG |
Estimated Market Risk
| 0.34 actual daily | 3 97% of assets are more volatile |
Expected Return
| -0.01 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.02 actual daily | 0 Most of other assets perform better |
Based on monthly moving average AB Corporate is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of AB Corporate by adding AB Corporate to a well-diversified portfolio.
AB Corporate Fundamentals Growth
EYEG Etf prices reflect investors' perceptions of the future prospects and financial health of AB Corporate, and AB Corporate fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on EYEG Etf performance.
| Return On Equity | -103.8 | |||
| Return On Asset | -40.35 | |||
| Current Valuation | 18.1 M | |||
| Shares Outstanding | 7.1 M | |||
| Price To Earning | (0.85) X | |||
| Price To Book | 1.55 X | |||
| Revenue | 12.06 K | |||
| EBITDA | (9.34 M) | |||
| Cash And Equivalents | 3.66 M | |||
| Cash Per Share | 0.29 X | |||
| Total Debt | 308.01 K | |||
| Debt To Equity | 0.03 % | |||
| Book Value Per Share | 1.26 X | |||
| Cash Flow From Operations | (8.66 M) | |||
| Earnings Per Share | (1.77) X | |||
| Total Asset | 10.62 M | |||
| Retained Earnings | (108.16 M) | |||
| Current Asset | 6.26 M | |||
| Current Liabilities | 6.16 M |
About AB Corporate Performance
By analyzing AB Corporate's fundamental ratios, stakeholders can gain valuable insights into AB Corporate's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if AB Corporate has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if AB Corporate has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
EyeGate Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on developing and commercializing products for treating inflammatory and immune diseases with a focus on the eye and nervous system in the United States. Eyegate Pharmaceuticals, Inc. was incorporated in 1998 and is headquartered in Waltham, Massachusetts. Eyegate Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 14 people.| AB Corporate Bond generated a negative expected return over the last 90 days | |
| The company reported the previous year's revenue of 12.06 K. Net Loss for the year was (9.47 M) with loss before overhead, payroll, taxes, and interest of (3.55 M). | |
| AB Corporate Bond currently holds about 3.66 M in cash with (8.66 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.29. | |
| Roughly 12.0% of the company shares are held by company insiders | |
| Latest headline from seekingalpha.com: AB Corporate Bond ETF goes ex dividend today |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in AB Corporate Bond. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
The market value of AB Corporate Bond is measured differently than its book value, which is the value of EYEG that is recorded on the company's balance sheet. Investors also form their own opinion of AB Corporate's value that differs from its market value or its book value, called intrinsic value, which is AB Corporate's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AB Corporate's market value can be influenced by many factors that don't directly affect AB Corporate's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AB Corporate's value and its price as these two are different measures arrived at by different means. Investors typically determine if AB Corporate is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AB Corporate's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.